By Counterforce Health Team in Revlimid (lenalidomide) —

Get Revlimid (Lenalidomide) Covered by Cigna in New York: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Revlimid (Lenalidomide) Covered by Cigna in New York

Revlimid (lenalidomide) requires prior authorization through Cigna Express Scripts, with mandatory FDA REMS program compliance. Start by ensuring your prescriber is REMS-certified and gather complete documentation: ICD-10 diagnosis codes, prior therapy records, recent labs, and treatment rationale per NCCN guidelines. Submit via the Cigna provider portal or fax with clinical notes. If denied, file internal appeals within 180 days, then external review through New York State Department of Financial Services within 4 months. New York's external review has overturned many specialty drug denials when proper evidence is provided.

First step today: Contact your oncologist/hematologist to confirm REMS enrollment status and schedule a visit to compile your evidence kit.

Table of Contents

  1. Set Your Goal: What Approval Requires
  2. Visit Preparation: Building Your Case
  3. Evidence Kit: Documentation You'll Need
  4. Medical Necessity Letter Structure
  5. Peer-to-Peer Support Strategy
  6. After-Visit Action Plan
  7. Appeals Process in New York
  8. Common Denial Reasons & Solutions
  9. When to Escalate
  10. FAQ

Set Your Goal: What Approval Requires

Getting Revlimid (lenalidomide) covered by Cigna means meeting both FDA safety requirements and insurance criteria. This high-cost oral cancer therapy (often >$15,000 per cycle) requires careful coordination between you and your healthcare team.

Coverage Requirements at a Glance

Requirement Details Documentation Needed
Prior Authorization Mandatory for all indications Provider portal/fax form with clinical rationale
REMS Compliance Prescriber certified; specialty pharmacy only Enrollment confirmation, patient agreement, pregnancy tests
Diagnosis FDA-approved (multiple myeloma, MDS, mantle cell lymphoma) ICD-10 codes, pathology reports, staging
Prior Therapy Often required for relapsed cases Names, dates, failure/intolerance documentation
Duration 12 months initial authorization Reauthorization with progression assessment

Your partnership with your oncologist or hematologist is crucial—they'll handle the technical submissions while you gather personal medical history and advocate for timely processing.

Visit Preparation: Building Your Case

Before your appointment, create a comprehensive timeline that strengthens your prior authorization request.

Symptom and Treatment Timeline

Document your cancer journey chronologically:

  • Initial diagnosis date and staging results
  • Previous treatments tried (chemotherapy, radiation, other medications)
  • Treatment outcomes (response, progression, side effects)
  • Current symptoms affecting daily function
  • Functional impact (work limitations, quality of life changes)

Questions to Prepare

  • "What specific FDA indication does my diagnosis meet for Revlimid?"
  • "Are you enrolled in the Lenalidomide REMS program?"
  • "What prior therapies should we document as failed or contraindicated?"
  • "Do I meet NCCN guideline criteria for this treatment?"
From our advocates: Patients who bring organized medical timelines to their appointments often see faster approvals. One multiple myeloma patient created a simple chart showing three failed treatments with dates and reasons for discontinuation—their PA was approved within a week because the medical necessity was crystal clear.

Evidence Kit: Documentation You'll Need

Your evidence kit should include both clinical records and supporting literature that demonstrates medical necessity.

Essential Clinical Documents

Recent Lab Results:

  • Complete blood count (CBC)
  • Comprehensive metabolic panel
  • Kidney and liver function tests
  • Beta-2 microglobulin levels (for multiple myeloma)

Imaging and Pathology:

  • Bone marrow biopsy results
  • CT/MRI/PET scans showing disease progression
  • Cytogenetic analysis (if applicable)

Treatment History:

  • Medication names and NDC codes
  • Start/stop dates for each therapy
  • Documented reasons for discontinuation
  • Side effect profiles and intolerances

Supporting Guidelines and Literature

Your provider should reference:

  • NCCN Multiple Myeloma Guidelines (Category 1 recommendations)
  • FDA prescribing information for approved indications
  • Peer-reviewed studies supporting efficacy in your specific condition

Counterforce Health specializes in compiling this exact type of evidence-backed documentation for complex prior authorization cases, helping patients and providers build stronger appeals with the right clinical citations.

Medical Necessity Letter Structure

Your oncologist will write the medical necessity letter, but understanding its key components helps ensure nothing is missed.

Essential Elements

1. Patient and Diagnosis

  • Full name, DOB, insurance ID
  • ICD-10 diagnosis codes (e.g., C90.00 for multiple myeloma)
  • Disease stage and risk stratification

2. Clinical Rationale

  • Why Revlimid is the appropriate next treatment
  • How it aligns with NCCN or ASCO guidelines
  • Expected treatment duration and goals

3. Prior Treatment History

  • Specific medications tried with dates
  • Reasons for discontinuation (progression, intolerance, contraindications)
  • Documentation of treatment failures

4. Risk of Delay

  • Potential for disease progression
  • Impact on overall survival or quality of life
  • Why alternative treatments are insufficient

5. Supporting References

  • NCCN guideline citations
  • Relevant clinical trial data
  • FDA labeling information

Clinician Corner: Key Documentation Checklist

Medical Necessity Letter Checklist:Patient diagnosis with ICD-10 codesPrior treatments and outcomes documentedClinical rationale per NCCN/ASCO guidelinesDosing and monitoring planRisk assessment for treatment delaySupporting literature citations

Peer-to-Peer Support Strategy

If Cigna requests a peer-to-peer review, you can support your provider's preparation.

How You Can Help

Provide Clear Availability:

  • Offer specific time windows when your provider is available
  • Understand that these calls can take 30-60 minutes
  • Be patient—80% of requests ultimately succeed despite initial delays

Prepare a Concise Case Summary: Create a one-page summary for your provider including:

  • Your diagnosis and current status
  • Previous treatments and why they failed
  • Current symptoms and functional limitations
  • Why Revlimid is specifically needed now

Key Talking Points for Your Provider

Your oncologist should emphasize:

  • Patient-specific evidence: Your high-risk features, progression patterns
  • Guideline support: NCCN Category 1 recommendations
  • Urgency factors: Risk of rapid progression in hematologic malignancies
  • Alternative limitations: Why other options are contraindicated or insufficient

After-Visit Action Plan

Once your provider submits the prior authorization, stay actively involved in the process.

What to Save and Track

  • Prior authorization submission confirmation (reference numbers, dates)
  • Provider portal communications and status updates
  • Insurance correspondence (approval letters, denial notices)
  • Pharmacy communications about REMS compliance

Follow-Up Strategy

Week 1: Confirm submission with provider office Week 2: Check status via Cigna member portal or phone Week 3: If no response, request expedited review if clinically urgent Week 4+: Prepare for potential appeal if denial received

Portal Communication Tips

When messaging your provider through patient portals:

  • Include specific questions about PA status
  • Attach any insurance correspondence you've received
  • Request copies of submitted documentation
  • Ask about backup treatment plans if denied

Appeals Process in New York

New York offers robust protection for patients facing insurance denials, with multiple levels of review available.

Internal Appeals with Cigna

First-Level Internal Appeal:

  • Deadline: 180 days from denial notice
  • Process: Submit written request with additional clinical evidence
  • Timeline: 15 days for standard, 72 hours for expedited
  • Contact: Cigna member services or provider portal

Second-Level Internal Appeal:

  • When: After first-level denial (optional but recommended)
  • Timeline: Additional 15 days for review
  • Evidence: New clinical information or expert opinions

New York External Review

If internal appeals fail, New York's Department of Financial Services External Appeal provides independent medical review.

Eligibility Requirements:

  • Completed internal appeal process (or waived it)
  • Denial based on medical necessity, experimental status, or formulary issues
  • Filed within 4 months of final internal denial

Expedited Review Available:

  • Timeline: 72 hours for standard, 24 hours for non-formulary drugs
  • Criteria: Immediate health risk or urgent medication needs
  • Contact: (888) 990-3991 for expedited requests

Filing Process:

  1. Complete DFS External Appeal Application
  2. Include patient consent, denial notices, clinical records
  3. Submit online via DFS Portal (preferred) or fax (800) 332-2729
  4. Independent medical experts review case
  5. Decision is binding on Cigna
Note: New York's external review system has overturned many specialty drug denials when proper clinical evidence is provided. The searchable appeals database shows precedents for similar oncology medications.

Common Denial Reasons & Solutions

Denial Reason Solution Strategy Key Documentation
Missing REMS Compliance Ensure prescriber and patient enrollment complete REMS authorization number, signed agreements, pregnancy tests
Insufficient Prior Therapy Document specific treatment failures with dates Medication names, duration, reasons for discontinuation
Off-Label Use Provide NCCN or compendium support Guideline excerpts, peer-reviewed literature
Quantity Limits Exceeded Justify dosing per FDA label or guidelines Prescribing information, weight-based calculations
Not Medically Necessary Strengthen clinical rationale with evidence Updated labs, imaging, expert consultation

Strengthening Your Appeal

When appeals are needed, Counterforce Health helps patients and providers turn insurance denials into targeted, evidence-backed appeals by identifying the specific denial basis and crafting point-by-point rebuttals aligned to the plan's own rules.

When to Escalate

State Regulatory Assistance

New York Department of Financial Services:

  • Consumer Helpline: (800) 342-3736
  • Online Complaints: DFS Consumer Portal
  • When to Contact: Procedural violations, missed deadlines, unfair practices

Community Health Advocates:

  • Helpline: (888) 614-5400
  • Services: Free counseling on insurance denials and appeals
  • Specialties: Complex medication appeals, external review assistance

Federal Resources

Centers for Medicare & Medicaid Services (for Medicare plans):

  • Contact: 1-800-MEDICARE
  • Scope: Medicare Advantage or Part D plans

FAQ

How long does Cigna prior authorization take for Revlimid in New York? Standard PA decisions are made within 15 days, but expedited reviews (for urgent cases) can be completed within 72 hours. REMS enrollment may add 1-2 weeks for new prescribers.

What if Revlimid is non-formulary on my Cigna plan? You can request a formulary exception with clinical justification. If denied, New York's expedited external review for non-formulary drugs provides decisions within 24-72 hours.

Can I request an expedited appeal if my cancer is progressing? Yes. Both Cigna and New York's external review system offer expedited processes for urgent medical needs. Contact (888) 990-3991 for immediate assistance with external appeals.

Does step therapy apply if I've tried treatments outside New York? Prior therapies from any location count toward step therapy requirements. Ensure your provider documents all previous treatments with dates and outcomes.

What happens if I can't afford Revlimid while appealing? Bristol Myers Squibb offers patient assistance programs. Contact their Patient Access Network at 1-855-692-7332. Some patients may qualify for temporary supplies during appeals.

How do I find a REMS-certified pharmacy in New York? The Lenalidomide REMS website provides a pharmacy locator. Most major specialty pharmacies (CVS Specialty, Express Scripts) are certified.

What if my oncologist isn't familiar with Cigna's requirements? Share this guide with your provider and suggest they contact Cigna's provider services for specific PA criteria. Many practices also work with prior authorization specialists.

Can I get help with the external appeal paperwork? Yes. Community Health Advocates (888-614-5400) provides free assistance with New York external appeals, including help completing forms and gathering documentation.

Sources & Further Reading

Disclaimer: This information is for educational purposes only and does not constitute medical or legal advice. Insurance coverage decisions depend on individual circumstances, plan terms, and clinical factors. Always consult with your healthcare provider and insurance company for specific guidance regarding your situation. Coverage policies and procedures may change; verify current requirements with official sources.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.